BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 17709469)

  • 1. In vitro and in vivo activities of novel fluoroquinolones alone and in combination with clarithromycin against clinically isolated Mycobacterium avium complex strains in Japan.
    Kohno Y; Ohno H; Miyazaki Y; Higashiyama Y; Yanagihara K; Hirakata Y; Fukushima K; Kohno S
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4071-6. PubMed ID: 17709469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.
    Bermudez LE; Kolonoski P; Petrofsky M; Wu M; Inderlied CB; Young LS
    J Infect Dis; 2003 Jun; 187(12):1977-80. PubMed ID: 12792877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro and in vivo antimicrobial activities of sitafloxacin, gatifloxacin and moxifloxacin against Mycobacterium avium.
    Sano C; Tatano Y; Shimizu T; Yamabe S; Sato K; Tomioka H
    Int J Antimicrob Agents; 2011 Apr; 37(4):296-301. PubMed ID: 21353489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
    Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS
    Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen.
    Koh WJ; Hong G; Kim SY; Jeong BH; Park HY; Jeon K; Kwon OJ; Lee SH; Kim CK; Shin SJ
    Antimicrob Agents Chemother; 2013 May; 57(5):2281-5. PubMed ID: 23478956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease.
    Koh WJ; Jeong BH; Jeon K; Lee SY; Shin SJ
    Am J Respir Crit Care Med; 2012 Oct; 186(8):797-802. PubMed ID: 22878282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial activity of picolinic acid against extracellular and intracellular Mycobacterium avium complex and its combined activity with clarithromycin, rifampicin and fluoroquinolones.
    Cai S; Sato K; Shimizu T; Yamabe S; Hiraki M; Sano C; Tomioka H
    J Antimicrob Chemother; 2006 Jan; 57(1):85-93. PubMed ID: 16303883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice.
    Bermudez LE; Inderlied CB; Kolonoski P; Wu M; Barbara-Burnham L; Young LS
    Antimicrob Agents Chemother; 1996 Mar; 40(3):546-51. PubMed ID: 8851568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial activities of clarithromycin, gatifloxacin and sitafloxacin, in combination with various antimycobacterial drugs against extracellular and intramacrophage Mycobacterium avium complex.
    Tomioka H; Sano C; Sato K; Shimizu T
    Int J Antimicrob Agents; 2002 Feb; 19(2):139-45. PubMed ID: 11850167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
    Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
    Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activities of moxifloxacin in combination with macrolides against clinical isolates of Mycobacterium abscessus and Mycobacterium massiliense.
    Choi GE; Min KN; Won CJ; Jeon K; Shin SJ; Koh WJ
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3549-55. PubMed ID: 22564831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
    Huang CC; Wu MF; Chen HC; Huang WC
    J Microbiol Immunol Infect; 2018 Oct; 51(5):636-643. PubMed ID: 28705770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
    Pellegrin I; Maugein J; Lapeyre C; Barbeau P; Leng B; Pellegrin JL
    J Antimicrob Chemother; 1996 Mar; 37(3):501-10. PubMed ID: 9182107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
    Ogawa K; Sano C
    Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clarithromycin-resistant mycobacterium avium is still susceptible to treatment with clarithromycin and is virulent in mice.
    Bermudez LE; Nash K; Petrofsky M; Young LS; Inderlied CB
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2619-22. PubMed ID: 10991834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative activities of azithromycin and clarithromycin against Mycobacterium avium infection in beige mice.
    Cynamon MH; Klemens SP; Grossi MA
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1452-4. PubMed ID: 7979270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice.
    Bermudez LE; Reynolds R; Kolonoski P; Aralar P; Inderlied CB; Young LS
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2685-7. PubMed ID: 12878542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of mouse models of Mycobacterium avium complex infection and evaluation of drug combinations.
    Andréjak C; Almeida DV; Tyagi S; Converse PJ; Ammerman NC; Grosset JH
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2129-35. PubMed ID: 25624335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activity and clinical efficacy of sparfloxacin in Mycobacterium avium-intracellulare complex infection.
    Horiguchi T; Kondo R; Miyazaki J; Shiga M; Sugiyama M; Handa M; Munekata E
    J Int Med Res; 2004; 32(5):530-9. PubMed ID: 15458286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of refractory disseminated Mycobacterium avium complex infection with the addition of linezolid and mefloquine.
    Nannini EC; Keating M; Binstock P; Samonis G; Kontoyiannis DP
    J Infect; 2002 Apr; 44(3):201-3. PubMed ID: 12099753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.